tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENTA Stock Latest News

Enanta announces passing of CFO Paul Mellet Jr.
The FlyEnanta announces passing of CFO Paul Mellet Jr.
17d ago
ENTA
Enanta initiated with a Buy at WestPark Capital
PremiumThe Fly
Enanta initiated with a Buy at WestPark Capital
17d ago
ENTA
Enanta Pharmaceuticals Appoints Interim Financial Officers
PremiumCompany Announcements
Enanta Pharmaceuticals Appoints Interim Financial Officers
23d ago
8K
ENTA
Enanta Pharmaceuticals Sues Pfizer Over Patent Infringement
PremiumCompany Announcements
Enanta Pharmaceuticals Sues Pfizer Over Patent Infringement
1M ago
8K
ENTA
Enanta files EU patent infringement suit against Pfizer
PremiumThe Fly
Enanta files EU patent infringement suit against Pfizer
1M ago
PFE
ENTA
Enanta Pharmaceuticals: Hold Rating Amid Strategic Advances and Financial Constraints
PremiumRatingsEnanta Pharmaceuticals: Hold Rating Amid Strategic Advances and Financial Constraints
1M ago
ENTA
Enanta Pharmaceuticals: Promising Outlook with Key Data Readouts and Strong Virology Pipeline
Premium
Ratings
Enanta Pharmaceuticals: Promising Outlook with Key Data Readouts and Strong Virology Pipeline
1M ago
ENTA
Enanta price target raised to $25 from $24 at Citizens JMP
Premium
The Fly
Enanta price target raised to $25 from $24 at Citizens JMP
1M ago
ENTA
Enanta Pharmaceuticals Reports Steady Progress in Q3 2025
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Steady Progress in Q3 2025
1M ago
ENTA
Enanta reports Q3 EPS (85c), consensus (88c)
PremiumThe Fly
Enanta reports Q3 EPS (85c), consensus (88c)
1M ago
ENTA
Is ENTA a Buy, Before Earnings?
PremiumPre-Earnings
Is ENTA a Buy, Before Earnings?
1M ago
ENTA
Enanta assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Enanta assumed with a Buy at H.C. Wainwright
2M ago
ENTA
Enanta price target raised to $24 from $23 at Citizens JMP
PremiumThe FlyEnanta price target raised to $24 from $23 at Citizens JMP
4M ago
ENTA
Enanta price target raised to $23 from $21 at Citizens JMP
Premium
The Fly
Enanta price target raised to $23 from $21 at Citizens JMP
4M ago
ENTA
Enanta Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
Enanta Pharmaceuticals Reports Q2 2025 Financial Results
4M ago
ENTA
Enanta reports Q2 EPS ($1.06), consensus ($1.14)
PremiumThe Fly
Enanta reports Q2 EPS ($1.06), consensus ($1.14)
4M ago
ENTA
Is ENTA a Buy, Before Earnings?
PremiumPre-Earnings
Is ENTA a Buy, Before Earnings?
4M ago
ENTA
Enanta Pharmaceuticals Stockholders Approve Key Proposals in 2025
PremiumCompany Announcements
Enanta Pharmaceuticals Stockholders Approve Key Proposals in 2025
6M ago
8K
ENTA
Enanta Pharmaceuticals: Hold Rating Amid Delayed Launches and Strategic Advancements
PremiumRatings
Enanta Pharmaceuticals: Hold Rating Amid Delayed Launches and Strategic Advancements
7M ago
ENTA
Enanta Pharmaceuticals Advances in Virology and Immunology
PremiumCompany AnnouncementsEnanta Pharmaceuticals Advances in Virology and Immunology
7M ago
ENTA
Enanta CEO buys $256K in common stock
Premium
The Fly
Enanta CEO buys $256K in common stock
7M ago
ENTA
Enanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
Premium
Ratings
Enanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
7M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >